AR213300A1 - Metanolato cristalino de 7-(d-2-hidroxi-2-fenilacetamido)-3-(1-metil-1h-tetrazol-5-iltrometil)-3-cefem-3-carboxilato de sodio,procedimiento para obtenerlo y procedimiento para convertir dicho metanolato en el anhidrato correspondiente - Google Patents
Metanolato cristalino de 7-(d-2-hidroxi-2-fenilacetamido)-3-(1-metil-1h-tetrazol-5-iltrometil)-3-cefem-3-carboxilato de sodio,procedimiento para obtenerlo y procedimiento para convertir dicho metanolato en el anhidrato correspondienteInfo
- Publication number
- AR213300A1 AR213300A1 AR265847A AR26584776A AR213300A1 AR 213300 A1 AR213300 A1 AR 213300A1 AR 265847 A AR265847 A AR 265847A AR 26584776 A AR26584776 A AR 26584776A AR 213300 A1 AR213300 A1 AR 213300A1
- Authority
- AR
- Argentina
- Prior art keywords
- procedure
- methanolate
- iltrometil
- cefem
- phenylacetamide
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Cephalosporin Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US05/642,922 US4054738A (en) | 1975-12-22 | 1975-12-22 | Sodium cefamandole crystalline forms |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR213300A1 true AR213300A1 (es) | 1979-01-15 |
Family
ID=24578600
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AR265847A AR213300A1 (es) | 1975-12-22 | 1976-12-14 | Metanolato cristalino de 7-(d-2-hidroxi-2-fenilacetamido)-3-(1-metil-1h-tetrazol-5-iltrometil)-3-cefem-3-carboxilato de sodio,procedimiento para obtenerlo y procedimiento para convertir dicho metanolato en el anhidrato correspondiente |
Country Status (31)
| Country | Link |
|---|---|
| US (1) | US4054738A (es) |
| JP (2) | JPS5282714A (es) |
| AR (1) | AR213300A1 (es) |
| AT (2) | AT348678B (es) |
| AU (1) | AU505924B2 (es) |
| BE (1) | BE849415A (es) |
| CA (1) | CA1080696A (es) |
| CH (1) | CH628348A5 (es) |
| CS (1) | CS195746B2 (es) |
| DD (1) | DD128727A5 (es) |
| DE (1) | DE2654647C2 (es) |
| DK (1) | DK153156C (es) |
| FI (1) | FI66008C (es) |
| FR (3) | FR2361898A1 (es) |
| GB (1) | GB1565854A (es) |
| GR (1) | GR65891B (es) |
| HU (1) | HU172474B (es) |
| IL (3) | IL50977A (es) |
| LU (1) | LU76435A1 (es) |
| MX (1) | MX3840E (es) |
| NL (1) | NL187483C (es) |
| NO (1) | NO148887C (es) |
| NZ (1) | NZ182694A (es) |
| OA (1) | OA05518A (es) |
| PH (1) | PH12191A (es) |
| PL (1) | PL102739B1 (es) |
| PT (1) | PT65955B (es) |
| RO (3) | RO75963A (es) |
| SE (3) | SE424730B (es) |
| SU (3) | SU637087A3 (es) |
| ZA (1) | ZA766957B (es) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4168376A (en) * | 1978-06-05 | 1979-09-18 | Eli Lilly And Company | Process for crystalline sodium cefamandole |
| US4237279A (en) * | 1979-07-27 | 1980-12-02 | Eli Lilly And Company | Crystalline 3-hydroxycephalosporin solvates |
| DE3313816A1 (de) * | 1983-04-16 | 1984-10-18 | Hoechst Ag, 6230 Frankfurt | Neue kristallmodifikation von ceftazidim |
| DE3313818A1 (de) * | 1983-04-16 | 1984-10-18 | Hoechst Ag, 6230 Frankfurt | Neue kristallmodifikation von ceftazidim |
| CA1242699A (en) * | 1985-02-01 | 1988-10-04 | Bristol-Myers Company | Cefbuperazone and derivatives thereof |
| JPH0677413B2 (ja) * | 1985-05-03 | 1994-09-28 | 株式会社フジクラ | 高圧直流送電用電力ケーブル |
| JPS629495U (es) * | 1985-07-01 | 1987-01-21 | ||
| GB9717629D0 (en) | 1997-08-21 | 1997-10-22 | Johnson Matthey Plc | Removal of residual organic solvents |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3496171A (en) * | 1969-02-17 | 1970-02-17 | Lilly Co Eli | Process for improving the physical and chemical properties of cephaloglycin |
| US3641021A (en) * | 1969-04-18 | 1972-02-08 | Lilly Co Eli | 3 7-(ring-substituted) cephalosporin compounds |
| US3692781A (en) * | 1971-02-26 | 1972-09-19 | Glaxo Lab Ltd | Recovery of pure cephalexin from acidic reaction mixtures |
| US3819620A (en) * | 1972-06-01 | 1974-06-25 | Squibb & Sons Inc | 7-(d-alpha-amino-1,4-cyclohexadien-1-ylacet-amido)desacetoxycephalosporanic acid dihydrate |
| US3862186A (en) * | 1972-12-15 | 1975-01-21 | Bristol Myers Co | Process for the production of cephalexin monohydrate |
| US3928592A (en) * | 1974-02-22 | 1975-12-23 | Lilly Co Eli | Antibiotic pharmaceutical compositions |
-
1975
- 1975-12-22 US US05/642,922 patent/US4054738A/en not_active Expired - Lifetime
-
1976
- 1976-11-18 GR GR52212A patent/GR65891B/el unknown
- 1976-11-19 CA CA266,112A patent/CA1080696A/en not_active Expired
- 1976-11-22 ZA ZA00766957A patent/ZA766957B/xx unknown
- 1976-11-23 NZ NZ182694A patent/NZ182694A/xx unknown
- 1976-11-24 IL IL50977A patent/IL50977A/xx unknown
- 1976-11-25 AU AU20013/76A patent/AU505924B2/en not_active Expired
- 1976-12-02 DE DE2654647A patent/DE2654647C2/de not_active Expired
- 1976-12-06 MX MX765190U patent/MX3840E/es unknown
- 1976-12-08 CH CH1543176A patent/CH628348A5/de not_active IP Right Cessation
- 1976-12-13 PT PT65955A patent/PT65955B/pt unknown
- 1976-12-13 NO NO764222A patent/NO148887C/no unknown
- 1976-12-14 AR AR265847A patent/AR213300A1/es active
- 1976-12-15 JP JP15143776A patent/JPS5282714A/ja active Granted
- 1976-12-15 BE BE1007825A patent/BE849415A/xx not_active IP Right Cessation
- 1976-12-15 FR FR7637750A patent/FR2361898A1/fr active Granted
- 1976-12-15 GB GB52235/76A patent/GB1565854A/en not_active Expired
- 1976-12-16 CS CS768302A patent/CS195746B2/cs unknown
- 1976-12-17 PH PH19260A patent/PH12191A/en unknown
- 1976-12-18 RO RO7696124A patent/RO75963A/ro unknown
- 1976-12-18 RO RO7696125A patent/RO75964A/ro unknown
- 1976-12-18 RO RO7688777A patent/RO69709A/ro unknown
- 1976-12-20 LU LU76435A patent/LU76435A1/xx unknown
- 1976-12-21 OA OA56020A patent/OA05518A/xx unknown
- 1976-12-21 NL NLAANVRAGE7614233,A patent/NL187483C/xx not_active IP Right Cessation
- 1976-12-21 DK DK575576A patent/DK153156C/da not_active IP Right Cessation
- 1976-12-21 AT AT948976A patent/AT348678B/de active
- 1976-12-21 HU HU76EI00000720A patent/HU172474B/hu unknown
- 1976-12-21 AT AT217578A patent/AT349148B/de not_active IP Right Cessation
- 1976-12-21 SE SE7614401A patent/SE424730B/xx not_active IP Right Cessation
- 1976-12-22 FI FI763682A patent/FI66008C/fi not_active IP Right Cessation
- 1976-12-22 PL PL1976194617A patent/PL102739B1/pl unknown
- 1976-12-22 DD DD7600196537A patent/DD128727A5/xx unknown
- 1976-12-22 SU SU762433502A patent/SU637087A3/ru active
-
1977
- 1977-05-20 FR FR7715576A patent/FR2351984A1/fr active Granted
- 1977-05-20 FR FR7715577A patent/FR2351985A1/fr active Granted
- 1977-11-17 SU SU772541708A patent/SU671732A3/ru active
- 1977-12-21 SU SU772556949A patent/SU1018585A3/ru active
-
1979
- 1979-05-23 IL IL57387A patent/IL57387A0/xx not_active IP Right Cessation
- 1979-05-23 IL IL57386A patent/IL57386A0/xx not_active IP Right Cessation
-
1982
- 1982-03-17 SE SE8201701A patent/SE443564B/sv not_active IP Right Cessation
- 1982-03-17 SE SE8201702A patent/SE441096B/sv not_active IP Right Cessation
-
1985
- 1985-05-24 JP JP60113022A patent/JPS6183189A/ja active Granted
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES493948A0 (es) | Procedimiento para generar halogenos | |
| AR220512A1 (es) | Procedimiento para la preparacion de 3-substituido-5-piridinil-2-(1h)-piridinonas | |
| FI791844A (fi) | Kontaktlinser med hoeg permeabilitet av gaser | |
| AR202618A1 (es) | Procedimiento para la preparacion de metiltioalquilguanidinas heterociclicas | |
| FR2319742A1 (fr) | Structure de joint etanche de dilata | |
| AR211629A1 (es) | Procedimiento para limpiar impurezas | |
| MX7282E (es) | Procedimiento para mejorar la permeabilidad de las rocas | |
| AR211887A1 (es) | Procedimiento para la preparacion de derivados de endolizina | |
| IT1085033B (it) | Procedimento per la preparazione di metossi-psorali | |
| AR213300A1 (es) | Metanolato cristalino de 7-(d-2-hidroxi-2-fenilacetamido)-3-(1-metil-1h-tetrazol-5-iltrometil)-3-cefem-3-carboxilato de sodio,procedimiento para obtenerlo y procedimiento para convertir dicho metanolato en el anhidrato correspondiente | |
| AR213831A1 (es) | Procedimiento para la preparacion de 11-desoxi-16-aril-omega-tetranorprostaglandina | |
| IT1064613B (it) | Perfezionamenti apportati ai giunti per la costruzione di telai | |
| MX4796E (es) | Procedimiento para la preparacion de derivados de 2-iminotiazolina | |
| MX4133E (es) | Procedimiento para la preparacion de n-tetrahidrofurfuril-noroximorfonas diastereoisomeras | |
| MX4858E (es) | Procedimiento para preparar compuestos de bis-carbamilguanidino-aza-alcano | |
| AR209498A1 (es) | Procedimiento para la preparacion de l-piroglutamil-l-pronilamida | |
| AR217664A1 (es) | Procedimiento para la preparacion de derivados de oleandomicina | |
| AR215650A1 (es) | Procedimiento para preparar 1,3-diaciloxi-2-(2-metil-1,3-benzodioxan-4-on-2-iloxi)-propanos | |
| AR211856A1 (es) | Procedimiento para producir derivados de 5-metil-1-fenil-1,3,4,6,-tetrahidro-5h-benzf2,5,-oxazocina | |
| MX3739E (es) | Procedimiento para la preparacion de acilamino-penicilinas-6-substituida | |
| MX3846E (es) | Procedimiento para la preparacion de 1-hidrocarburo-3 3-difenil-4-hidroximetil-2-pirrolidinonas | |
| IT1085866B (it) | Procedimento per preparare solfon-acetali | |
| AR221240A1 (es) | Procedimiento para obtener metanolato cristalino del 7-d-mandelamido-3-(1-metil-1h-tetrazol-5-iltiometil)-3-cefem-4-carboxilato de sodio y el metanolato asi obtenido | |
| AR213309A1 (es) | Procedimiento para preparar 2-amino-isotioureidobencenos substituidos | |
| MX4618E (es) | Procedimiento para la preparacion de derivados de hidrazinopiridazina |